510(k) Report

510(k) · Cleared

Cleared

Synchron Systems Thyroxine Reagent

K971203510(k) TraditionalCleared May 16, 199745-day reviewClass II21 CFR 862.1700

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Beckman Instruments, Inc. · KLI Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine

Cleared on May 16, 1997 as substantially equivalent to K942575 (Microgenics Corp., 1994) after a 45-day review. Its family tree reaches back 1 generation to 1994.

Decided
May 16, 1997
Review
45 days
Class
Class II
Product code
KLI
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K942575 (1994). No later device cites it as a predicate yet.

K942575 · Cedia T4 Mab Assay · Microgenics Corp. · 199419901992199419961998
K942575 · Cedia T4 Mab Assay · Microgenics Corp. · 19940
  1. Root · 1 generation backK942575 Cedia T4 Mab AssayMicrogenics Corp. · 1994
  2. This deviceK971203 Synchron Systems Thyroxine ReagentBeckman Instruments, Inc. · 1997
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K942575Cedia T4 Mab AssayMicrogenics Corp.1994—
0 (this device)K971203Synchron Systems Thyroxine ReagentBeckman Instruments, Inc.1997—
FIG. 1 — Lineage of K971203, 1994–1997Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KLI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K942575Cedia T4 Mab Assay
Summary page 1
…2.1700) 4.0 Predi Vi SYNCHRON Systems | CEDIA T4 MAb Boehringer Mannheim Thyroxine (T4) Reagent | Reagent Corp., SYNCHRON Systems | CEDIA T4 MAD Boehringer Mannheim | K942575 Reagent- SYNCHRON Application Cormp., Thyroxine (T4) Reagent t4_510k.sse Beckman Instruments, Inc., Section 5…
Microgenics Corp.1994—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All KLI devices

KLI Enzyme Immunoassay, Non-Radiolabeled, Total Thyroxine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · KLI

1in 2016

2009: 12011: 12013: 12016: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KLI

Too few KLI 510(k)s in any year since 2007 to give a median.

Recalls per year · KLI

2in 2021

2010: 12011: 12021: 22026 (partial year): 1
2007high 2 (2021) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KLI

3in 2021

2010: 32011: 72012: 22014: 52018: 32019: 12021: 3
2007high 7 (2011) · low 0 (2007)2025

MAUDE reports naming product code KLI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20091—00
20100—13
20111—17
20120—02
20131—00
20140—05
20150—00
20161—00
20170—00
20180—03
20190—01
20200—00
20210—23
20220—00
20230—00
20240—00
20250—00
20260—1—

What is it indicated for?

The SYNCHRON Systems Thyroxine (T4) Reagent is intended for the quantitative determination of total thyroxine concentrations in serum on SYNCHRON Clinical Systems.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K971203: Synchron Systems Thyroxine Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K971203

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026